Bioavailability of Levodopa 250 mg and Carbidopa 25 mg With Regards to Reference Product
Condition: Bioequivalence Interventions: Drug: Levodopa 250mg and Carbidopa 25mg Test Drug tablet; Drug: Levodopa 250mg and Carbidopa 25mg Referent Product tablet Sponsor: Laboratorios Andromaco S.A. Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 22, 2022 Category: Research Source Type: clinical trials
Review of the recruitment process for a large investigator-initiated trial in early Parkinson ’s disease
We describe the organization of the Levodopa in the Early Parkinson ’s disease (LEAP) trial and the results of an external assessment of the recruitment process.MethodsSeveral strategies were used to ensure that recruitment for the trial was effective and efficient. We analyzed the patterns in referrals, inclusions, and non-inclusions to investigate whether there were bottlenecks in the referral and inclusion process. For the external assessment of the recruitment process, the QuinteT Recruitment Intervention (QRI-Two) was used retrospectively, focusing on finding possible issues impeding recruitment that are less easily...
Source: Trials - February 14, 2022 Category: Research Source Type: clinical trials
Comparative Bioavailability Study of Carbidopa/Levodopa Extended-Release Tablets Under Fasting and Fed Conditions
Condition: Parkinson Disease Intervention: Drug: WD-1603 Carbidopa-Levodopa Extended-Release Tablets Sponsor: Shanghai WD Pharmaceutical Co., Ltd. Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 19, 2021 Category: Research Source Type: clinical trials
